AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 229 filers reported holding AMICUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $172,532 | -64.1% | 25,601 | -38.4% | 0.02% | -59.1% |
| Q4 2021 | $480,000 | -31.0% | 41,582 | -76.5% | 0.04% | +33.3% |
| Q3 2021 | $696,000 | +121.7% | 176,600 | -23.6% | 0.03% | +94.1% |
| Q2 2021 | $314,000 | +5.0% | 231,100 | -5.9% | 0.02% | -19.0% |
| Q1 2021 | $299,000 | +94.2% | 245,500 | +156.8% | 0.02% | +50.0% |
| Q4 2020 | $154,000 | +94.9% | 95,600 | +218.7% | 0.01% | +7.7% |
| Q2 2020 | $79,000 | +7800.0% | 30,000 | -8.5% | 0.01% | – |
| Q3 2019 | $1,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
| Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
| Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
| Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
| CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
| Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
| Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
| Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
| Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
| Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |